Research Paper Volume 15, Issue 20 pp 11489—11507
Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology
Figure 9. The ((A) a–d) showed the results observed under the inverted microscope after being treated by different concentrations of formononetin for 48 h. Meanwhile, ((B) a′–d′) showed the results treated with DAPI for 48 h to assess cell apoptosis. (a, a′) The MG63 cells were treated with 0μg/mL Form for 48 h (the control group). (b, b′) The MG63 cells were treated with 5 μg/mL Form for 48 h. (c, c′) The MG63 cells were treated with 8 μg/mL Form for 48 h. (d, d′) The MG63 cells were treated with 10 μg/mL Form for 48 h.